The post XRP Price Prediction: Targets $2.20 by March 2026 Despite Current Bearish Momentum appeared on BitcoinEthereumNews.com. Caroline Bishop Feb 10, 2026The post XRP Price Prediction: Targets $2.20 by March 2026 Despite Current Bearish Momentum appeared on BitcoinEthereumNews.com. Caroline Bishop Feb 10, 2026

XRP Price Prediction: Targets $2.20 by March 2026 Despite Current Bearish Momentum



Caroline Bishop
Feb 10, 2026 05:48

XRP Price Prediction Summary • Short-term target (1 week): $1.48-$1.52 • Medium-term forecast (1 month): $1.85-$2.20 range • Bullish breakout level: $1.66 • Critical support: $1.33 What Crypt…

XRP Price Prediction Summary

• Short-term target (1 week): $1.48-$1.52
• Medium-term forecast (1 month): $1.85-$2.20 range
• Bullish breakout level: $1.66
• Critical support: $1.33

What Crypto Analysts Are Saying About Ripple

While specific analyst predictions are limited in the past 24 hours, recent market commentary from established voices provides insight into XRP’s trajectory. Dominic Basulto recently stated: “After a short-lived rally to start the year, XRP is once again trading below the $2 price level… I’m going to take a contrarian view on XRP. There are plenty of signs that the world’s fifth-largest cryptocurrency is ready to break out in 2026, and I’m predicting that XRP will double in price this year to hit the $4 mark.”

CoinCodex forecasts more modest gains, predicting XRP will trade between $1.84 and $2.96 throughout 2026, with an average price of $2.21. Meanwhile, Polymarket indicates XRP has a strong probability of reaching $2.60 before January 2027, citing “recent price action demonstrating capability to approach this level, combined with favorable regulatory developments, institutional catalysts, and broader crypto market trends.”

According to on-chain data, XRP’s current positioning suggests accumulation phases may be forming despite the recent price decline.

XRP Technical Analysis Breakdown

XRP’s current technical setup presents a mixed picture with both concerning and promising signals. Trading at $1.44, the token has declined 0.73% in the past 24 hours, establishing a trading range between $1.46 and $1.37.

The RSI reading of 35.14 places XRP in neutral territory but approaching oversold conditions, historically a favorable zone for contrarian plays. The MACD histogram at 0.0000 indicates bearish momentum has stalled, potentially signaling an impending directional shift.

Ripple’s position within the Bollinger Bands reveals significant technical insights. With a %B position of 0.2393, XRP is trading in the lower portion of its 20-day volatility range, suggesting oversold conditions. The price sits well below the middle band at $1.66, which now acts as immediate resistance.

Moving averages paint a bearish picture across all timeframes. The 7-day SMA at $1.42 provides minimal support, while the 20-day SMA at $1.66 represents the first major resistance hurdle. The concerning aspect is XRP’s position relative to longer-term averages, trading significantly below the 200-day SMA at $2.43.

Ripple Price Targets: Bull vs Bear Case

Bullish Scenario

The bulls need XRP to reclaim the $1.48 immediate resistance level to gain momentum. A successful break above this zone could target the strong resistance at $1.52, followed by the critical 20-day SMA at $1.66.

Breaking above $1.66 would represent a significant technical achievement, potentially opening the path toward the $1.85-$2.20 range that aligns with analyst forecasts. The ultimate bullish target remains the upper Bollinger Band at $2.09, which could serve as a stepping stone toward higher levels.

Technical confirmation for the bullish case requires RSI to break above 45 and MACD to generate a positive crossover signal. Volume expansion above the current $234 million daily average would provide additional confirmation.

Bearish Scenario

The immediate support at $1.39 represents the first line of defense for XRP holders. A breakdown below this level could accelerate selling toward the strong support at $1.33, which aligns closely with the lower Bollinger Band at $1.23.

Further deterioration could target psychological support zones around $1.20, representing a 17% decline from current levels. The bearish scenario gains credibility if RSI drops below 30 into oversold territory while maintaining bearish MACD momentum.

Should You Buy XRP? Entry Strategy

Current technical conditions suggest a cautious approach for new XRP positions. The optimal entry strategy involves waiting for either a clear reversal signal or a deeper pullback to stronger support levels.

Conservative buyers should consider dollar-cost averaging between $1.33-$1.39, representing the confluence of technical support and Bollinger Band lower regions. More aggressive traders might enter on a confirmed break above $1.48 with volume confirmation.

Risk management remains crucial with stop-loss orders suggested below $1.30 for long positions. Position sizing should account for XRP’s daily ATR of $0.15, indicating moderate volatility that could accelerate during breakout scenarios.

Conclusion

This XRP price prediction suggests cautious optimism for Ripple’s medium-term prospects despite current technical weakness. While immediate pressure persists below key moving averages, oversold RSI conditions and analyst targets in the $2.20 range support potential upside by March 2026.

The Ripple forecast hinges on reclaiming the $1.66 resistance level, which would validate the bullish thesis and open pathways toward analyst price targets. However, failure to hold $1.33 support could extend the correction toward $1.20.

This analysis is for educational purposes only and should not be considered financial advice. Cryptocurrency investments carry significant risk, and past performance does not guarantee future results. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock

Source: https://blockchain.news/news/20260210-price-prediction-xrp-targets-220-by-march-2026-despite

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.0005241
$0.0005241$0.0005241
+11.91%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26